Match the following complex nephrologic and acid-base clinical presentations with their mo… — USMLE Step 2 CK

Match the following complex nephrologic and acid-base clinical presentations with their most appropriate specific therapeutic interventions.

A 55-year-old with chronic voluminous diarrhea presenting with a serum bicarbonate of $14 \text{ mEq/L}$ , a normal anion gap, hypokalemia, and a urine anion gap of $-15 \text{ mEq/L}$ .Administration of oral potassium and alkali replacement to correct losses from the lower gastrointestinal tract.
A 35-year-old with Sjögren syndrome presenting with a serum bicarbonate of $16 \text{ mEq/L}$ , a normal anion gap, hypokalemia, a urine anion gap of $+25 \text{ mEq/L}$ , and a urine pH of $6.8$ .Initiation of alkali therapy, such as potassium citrate, to correct an impaired distal tubular hydrogen ion secretion.
A 65-year-old with long-standing diabetic nephropathy presenting with a serum bicarbonate of $18 \text{ mEq/L}$ , a normal anion gap, serum potassium of $5.8 \text{ mEq/L}$ , a urine anion gap of $+18 \text{ mEq/L}$ , and a urine pH of $5.2$ .Administration of loop diuretics or fludrocortisone to manage hyporeninemic hypoaldosteronism and facilitate potassium excretion.
A 60-year-old with advanced heart failure presenting with hypervolemic hyponatremia (serum sodium $118 \text{ mEq/L}$ ) that remains refractory to fluid restriction and escalating doses of loop diuretics.Initiation of a vasopressin-2 receptor antagonist (e.g., tolvaptan) to promote free water excretion (aquaresis).
A 70-year-old with small cell lung cancer who is brought to the emergency department actively seizing, with a serum sodium of $112 \text{ mEq/L}$ , urine osmolality of $600 \text{ mOsm/kg}$ , and euvolemia on physical examination.Immediate intravenous infusion of $3\%$ hypertonic saline to rapidly increase serum sodium and halt neurologic deterioration.

Answer

The correct pairings match gastrointestinal losses to oral potassium and alkali replacement; Type 1 RTA to alkali therapy; Type 4 RTA to loop diuretics or fludrocortisone; refractory heart failure hyponatremia to vaptans; and symptomatic severe SIADH to 3% hypertonic saline.

The correct matches appropriately pair the underlying pathophysiology of distinct nephrologic and acid-base disturbances with their specific targeted interventions. Identifying whether a non-anion gap metabolic acidosis is renal or gastrointestinal in origin relies on the Urine Anion Gap (

\text{UAG} = Na^+ + K^+ - Cl^-

). The UAG estimates urinary ammonium (

NH_4^+

) excretion. A negative UAG points to extrarenal GI losses requiring oral replacement. A positive UAG with hypokalemia and a urine pH

> 5.5

indicates Type 1 RTA, treated with alkali. A positive UAG with hyperkalemia indicates Type 4 RTA, treated by lowering potassium. For hyponatremia, refractory hypervolemic cases in heart failure are an indication for vaptans, whereas severe symptomatic cases (e.g., seizures) always require immediate

3\%

hypertonic saline.

Step-by-Step Solution

Analyze the acid-base parameters and urine anion gap (UAG) for the first three patients.

Patient 1 has a negative UAG (GI loss). Patient 2 has a positive UAG, hypokalemia, and urine pH > 5.5 (Type 1 RTA). Patient 3 has a positive UAG, hyperkalemia, and urine pH < 5.5 (Type 4 RTA).

UAG estimates urinary ammonium excretion; a negative UAG indicates an intact renal response (extrarenal cause), while a positive UAG indicates a renal acidification defect (RTA).

Select the appropriate targeted intervention for each acid-base disorder.

GI losses require oral replacement. Type 1 RTA requires alkali to correct the distal defect. Type 4 RTA requires potassium-lowering agents like fludrocortisone or loop diuretics.

Therapies must strictly target the specific pathophysiological defect causing the acidosis.

Evaluate the volume status and symptom severity for the patients with hyponatremia.

Patient 4 has refractory hypervolemic hyponatremia (heart failure). Patient 5 has euvolemic hyponatremia (SIADH) with severe neurologic symptoms (seizures).

Hyponatremia management is dictated first by symptom severity (seizures require 3% saline) and then by volume status.

Match the hyponatremia presentations to their interventions.

Patient 4 matches with vasopressin-2 receptor antagonists (tolvaptan). Patient 5 matches with immediate 3% hypertonic saline.

Vaptans promote aquaresis in volume-overloaded states, while hypertonic saline rapidly reverses life-threatening cerebral edema.

Key Concept

Differentiation of non-anion gap metabolic acidoses using the urine anion gap and serum potassium, alongside targeted management of euvolemic and hypervolemic hyponatremia based on symptom severity.

Estimated Time:2m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic